Market Tracker

03/27 6:01pm ET

Nektar Therapeutics (NASDAQ:NKTR)

During the Trading Day
11.09 +0.18 / +1.65%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.09 0.00 / 0.00%
 
Volume: 162.9K

Today’s Trading

Previous close10.91
Today’s open10.91
Day’s range10.70 - 11.17
Volume1,771,774
Average volume (3 months)1,199,169
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)+8.27%
Earnings growth (next 5 years)-8.06%
Revenue growth (last year)+34.77%
P/E ratioNM
Price/Sales9.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.22+2.69%
KERXKeryx Biopharmaceuti...-0.08-0.63%
FGENFibroGen Inc+0.34+1.15%
PRAHPRA Health Sciences ...-0.17-0.59%
Data as of 4:00pm ET, 03/27/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts